Although PSA is a highly sensitive marker, it is also relatively nonspecific and inaccurate as a screening tool, because both benign and malignant processes lead to an increase in serum levels of this marker.16This underscores the importance for the development of new molecular markers and further investigations in this field to enhance cancer detection and management. This evidence concerns the gene KLK3 and cancer.